Associations of Perilipin 3 with Insulin Resistance in Arab Adults with Type 2 Diabetes
Table 1
Clinical characteristics of subjects according to groups.
Parameters
HL
OND
OD
value
N (M/F) (127/153)
85 (41/44)
100 (46/54)
95 (40/55)
Age (years)
AB
<0.001
BMI (kg/m2)
A
AB
<0.001
Waist (cm)
A
A
<0.001
Hips (cm)
A
AB
<0.001
WHR
AB
0.005
Systolic BP (mmHg)
A
AB
<0.001
Diastolic BP (mmHg)
A
AB
<0.001
Glucose (nmol/L)
AB
<0.001
Total cholesterol (nmol/L)
AB
<0.001
HDL cholesterol (nmol/L)
A
A
<0.001
Triglycerides# (nmol/L)
1.2 (0.8-1.7)
1.5 (1.0-2.4)A
2.2 (1.7-3.5)AB
<0.001
Insulin# (μIU/mL)
3.8 (1.8-7.4)
9.1 (4.1-14.3)
14.1 (6.1-34)AB
<0.001
HOMA-IR#
0.78 (0.3-1.6)
1.9 (0.9-3.3)A
7.0 (2.8-16.3)AB
<0.001
PLIN3# (ng/mL)
23.1 (6.2-39.1)
15.1 (3.4-32.8)
8.3 (1.2-22.5)AB
<0.001
Note: data presented as for normal and median (interquartile range for nonnormal variables). Superscript “A” indicates significant difference from HL, and superscript “B” indicates significance compared to OND. Significant at . BMI: body mass index; BP: blood pressure; HDL: high-density lipoprotein; HOMA-IR: homeostasis insulin resistance; PLIN3: perilipin 3; WHR: waist-hip ratio.
